Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
BXQ-350 by Bexion Pharmaceuticals for Pediatric Diffuse Intrinsic Pontine Glioma: Likelihood of Approval
BXQ-350 is under clinical development by Bexion Pharmaceuticals and currently in Phase II for Pediatric Diffuse Intrinsic Pontine Glioma. According...
Data Insights
BXQ-350 by Bexion Pharmaceuticals for Malignant Glioma: Likelihood of Approval
BXQ-350 is under clinical development by Bexion Pharmaceuticals and currently in Phase II for Malignant Glioma. According to GlobalData, Phase...